Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fondaparinux sodium 5mg/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fondaparinux (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 12.5mg/mL injection solution 0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 12.5mg/mL injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 12.5mg/mL injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
fondaparinux sodique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fondaparinux sodium 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Fondaparinux sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |